MedTrace Logo

Neutrophil Lymphocyte Ratio as a Predictor of Outcome in Critically Traumatic Patients

NCT02749487 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2016-12-16

No results posted yet for this study

Summary

Neutrophil lymphocyte ratio NLR is an important index that evaluate the inflammatory status . It is a cost effective and readily available , and simply calculated , so that why investigators try to use it as a predictor of short term survival in the critically ill patients

Conditions

  • Critical Care

Interventions

OTHER

Neutrophil Lymphocyte Ratio

Neutrophil:lymphocyte ratio (NLR) is an emerging biomarker that is used to predict mortality and morbidity. The association of this biomarker with systemic illness and its usefulness in risk assessment of critically ill patients has not been fully elucidated.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-05-31
Completion
2016-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02749487 on ClinicalTrials.gov